Noom Med vs OrderlyMeds (2026): prices, structure, verdict

On tirzepatide, only OrderlyMeds↗ has a rankable figure: $299 a month all-in; Noom Med↗ does not offer tirzepatide.

Updated 2026-08-10 · figures captured 2026-08-09 · how we verify

On semaglutide, OrderlyMeds is cheaper: $149 versus $199 a month all-in — a $50 monthly gap, $600 across a year of maintenance dosing.

§ Side by side

§ Each record, read aloud

The two records, condensed

Noom Med: the record, condensed

Start with the load-bearing figure: $199 a month, all-in, is what Noom Med charges for semaglutide at the 2.4 mg basis. The price is dose-flat: the standard titration ladder (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg) is financially invisible here, because the top rung bills exactly what the bottom rung billed. That converts the advertised number from a floor into a ceiling — the strongest single structural feature a program in this category can have.

There is no membership line. $199 is the billed total — consultation and clinical review are inside it, and no platform fee recurs beside it, which removes the most common way advertised GLP-1 prices understate billed ones.

Context for that figure: it ranks #12 of 20 in the verified semaglutide index — $66/month above the floor (Oak Longevity, $133) — and sits $150 under the brand benchmark (Wegovy (NovoCare↗), $349 at maintenance). Annualized, a monthly-billed year here runs $2,388.

Operationally at Noom Med: shipping included; commitment 12-week cycles; cancellation 12-week billing cycles; pharmacy named (Tailor Made Compounding (named)); states: most states; evidence source-verified, captured 2026-08-08. The full record with source and archive links: the Noom Med page · visit Noom Med ↗

OrderlyMeds: the record, condensed

On tirzepatide, the number that matters at OrderlyMeds is $299 a month all-in — the figure at the 10 mg maintenance basis this whole site ranks on. It is a flat structure: 2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available) all bill identically. In a market where most low advertised prices quietly belong to the starter dose, a flat figure is the difference between a quote and a teaser.

There is no membership line. $299 is the billed total — consultation and clinical review are inside it, and no platform fee recurs beside it, which removes the most common way advertised GLP-1 prices understate billed ones.

To place the number: #8 of 17 verified programs, with the floor $84/month below at NexLife↗ ($215); the approved-product yardstick (Zepbound (LillyDirect↗)) sits at $449, so the compounded case here is worth $150 a month. A year at this figure: $3,588 monthly-billed.

OrderlyMeds’s semaglutide program bills $149 a month once every mandatory fee is counted, measured at the 2.4 mg maintenance basis. Because pricing is flat across the ladder (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg), a dose increase at OrderlyMeds is a clinical event and not a billing one. Whatever your prescriber decides, the invoice does not move, which makes this one of the few programs whose headline figure you can actually plan a year around.

Nothing recurs on top: no membership, no platform fee, no “provider access” line. The $149 is the whole subscription, which makes OrderlyMeds unusually easy to compare and unusually easy to leave.

Context for that figure: it ranks #4 of 20 in the verified semaglutide index — $16/month above the floor (Oak Longevity, $133) — and sits $200 under the brand benchmark (Wegovy (NovoCare), $349 at maintenance). Annualized, a monthly-billed year here runs $1,788.

Operationally at OrderlyMeds: shipping included; commitment none stated; cancellation not published; pharmacy not publicly named — ask in writing before paying; states: not published; evidence no public price, captured 2026-08-05. The full record with source and archive links: the OrderlyMeds page · visit OrderlyMeds ↗

Semaglutide: the duel in full

The semaglutide arithmetic between these two is short: $149 (OrderlyMeds) against $199 (Noom Med). $50 a month sounds survivable; $600 a year is a decision.

Both figures are dose-flat, which is the cleanest possible comparison: two ceilings, no titration surprises on either side, and the $50 gap is exactly what it appears to be.

A way to feel the $50 monthly gap: over a year it funds 4.0 extra months at OrderlyMeds’s own rate — the difference is not decoration, it is medication. Over two years it compounds to $1,200, which is the horizon at which structural details (prepaid ladders, membership drag, dose-tier repricing) start mattering more than the sticker itself.

Run the same two programs on the committed basis: Noom Med $199/mo month-to-month against OrderlyMeds $149/mo month-to-month. The order holds: OrderlyMeds leads on both readings, so plan structure sharpens the verdict here rather than reversing it. Whichever basis fits your commitment level, the upfront totals above are the honest units.

§ The clock, run forward

Three, six, twelve, twenty-four months — best path each way

3 months: Noom Med $597 monthly; OrderlyMeds $447 monthly — best path favors OrderlyMeds by $150. 6 months: Noom Med $1,194 monthly; OrderlyMeds $894 monthly — best path favors OrderlyMeds by $300. 12 months: Noom Med $2,388 monthly; OrderlyMeds $1,788 monthly — best path favors OrderlyMeds by $600. 24 months: Noom Med $4,776 monthly; OrderlyMeds $3,576 monthly — best path favors OrderlyMeds by $1,200.

Prepaid paths above are billed upfront and assume the published rate holds (the 24-month figures extend the 12-month rate, an assumption worth naming). The honest reading: over short horizons the monthly gap decides; over long horizons the prepaid ladders and structural traps (dose tiers, memberships) take over — which is exactly the split the verdict section below scores.

§ Structure vs structure

Everything besides the price

Coverage: Noom Med publishes “most states”; OrderlyMeds publishes “not published” — for anything short of an explicit 50-state claim, intake is the final word.

Pharmacy transparency splits them: Noom Med names its network (Tailor Made Compounding (named)); OrderlyMeds does not, which shifts the burden of verification onto your intake questions.

Exit terms: Noom Med — 12-week cycles; 12-week billing cycles. OrderlyMeds — none stated; not published.

Evidence: Noom Med source-verified (captured 2026-08-08); OrderlyMeds no public price (2026-08-05). Where a figure is stated-not-verified, weight it accordingly — it is a claim we could not capture on the company’s own pages.

The pattern worth internalizing: in this market, structural honesty and price honesty travel together. Programs that publish pharmacies and state lists tend to publish real maintenance prices; programs that hide one usually hide the other.

In the full semaglutide index these two sit at #12 and #4 of 20: between them lie 7 other programs, and the whole ladder is at cheapest semaglutide providers.

§ If you move

Switching between Noom Med and OrderlyMeds

Prescriptions do not transfer like phone numbers: moving in either direction means completing the destination’s intake and having its prescriber write a new patient-specific prescription. The mechanics that prevent a bad month: confirm the destination serves your state and quotes your current dose in writing before cancelling anything; time the first new shipment to overlap the last old one rather than gap it; cancel the origin per its published terms (Noom Med: 12-week billing cycles; OrderlyMeds: not published) and screenshot the confirmation; and never leave a prepaid balance stranded — which is the standing argument for prepaying only after a program has already earned a few monthly cycles.

§ Verdict by situation

Which one, for whom

§ More pairings